Genzyme Corporation to Pay FDA $175M in Settlement

April 21, 2010 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

Boston Business Journal -- Drug developer Genzyme Corp. of Cambridge has agreed to pay the Food and Drug Administration $175 million to settle manufacturing enforcement action, the company disclosed in a regulatory filing Wednesday.

Twitter
LinkedIn
Facebook
Email
Print

Legal

Food and Drug Administration (FDA)